TY - JOUR
T1 - Copy number assessment of SMN1 based on real-time PCR with high-resolution melting
T2 - fast and highly reliable testing
AU - Xu, Ying
AU - Song, Tingting
AU - Wang, Xiaozhou
AU - Zheng, Jiao
AU - Li, Yu
AU - Guo, Fenfen
AU - Li, Yuanfeng
AU - Guo, Zijian
AU - Dou, Yaling
AU - Wang, Yu
AU - Zhao, Ye
AU - Yang, Hong
N1 - Publisher Copyright:
© 2022 The Japanese Society of Child Neurology
PY - 2022/8
Y1 - 2022/8
N2 - Background: Spinal muscular atrophy (SMA) is a neuromuscular disease mainly caused by the absence of both copies of the survival motor neuron 1 (SMN1) gene. Multiple regions recommended population-wide SMA screening to quantify the copy number of SMN1. SMN1 diagnostic assays for the simplified procedure, high sensitivity, and throughput continue to be needed. Methods: Real-time PCR with high-resolution melting for the quantifying of the SMN1 gene exon 7 copies and exon 8 copies were established and confirmed by multiplex ligation-dependent probe amplification (MLPA). The diagnosis of 2563 individuals, including SMA patients, suspected cases, and the general population, was tested by real-time PCR. The results were compared with the gold standard test MLPA. Results: In this study, the homozygous and heterozygous deletions were detected by real-time PCR with a high-resolution melting method with an incidence of 10.18% and 2.26%, respectively. In addition, the R-value distribution (P > 0.05) among 8 replicates and the coefficient of variation (CV < 0.003) suggested that the real-time PCR screening test had high reproducibility. High concordance was obtained between real-time PCR with high-resolution melting and MLPA. Conclusions: The real-time PCR based on high-resolution melting provides a sensitive and high-throughput approach to large-scale SMA carrier screening with low cost and labor.
AB - Background: Spinal muscular atrophy (SMA) is a neuromuscular disease mainly caused by the absence of both copies of the survival motor neuron 1 (SMN1) gene. Multiple regions recommended population-wide SMA screening to quantify the copy number of SMN1. SMN1 diagnostic assays for the simplified procedure, high sensitivity, and throughput continue to be needed. Methods: Real-time PCR with high-resolution melting for the quantifying of the SMN1 gene exon 7 copies and exon 8 copies were established and confirmed by multiplex ligation-dependent probe amplification (MLPA). The diagnosis of 2563 individuals, including SMA patients, suspected cases, and the general population, was tested by real-time PCR. The results were compared with the gold standard test MLPA. Results: In this study, the homozygous and heterozygous deletions were detected by real-time PCR with a high-resolution melting method with an incidence of 10.18% and 2.26%, respectively. In addition, the R-value distribution (P > 0.05) among 8 replicates and the coefficient of variation (CV < 0.003) suggested that the real-time PCR screening test had high reproducibility. High concordance was obtained between real-time PCR with high-resolution melting and MLPA. Conclusions: The real-time PCR based on high-resolution melting provides a sensitive and high-throughput approach to large-scale SMA carrier screening with low cost and labor.
KW - Carrier screening
KW - High-resolution melting
KW - SMN1
KW - Spinal muscular atrophy
UR - https://www.scopus.com/pages/publications/85127892046
U2 - 10.1016/j.braindev.2022.03.011
DO - 10.1016/j.braindev.2022.03.011
M3 - 文章
C2 - 35414447
AN - SCOPUS:85127892046
SN - 0387-7604
VL - 44
SP - 462
EP - 468
JO - Brain and Development
JF - Brain and Development
IS - 7
ER -